AUTOIMMUNITY

Autoimmunity, auto immune disease, when the immune system wrongfully attacks healthy cells, is a product of genetic/environmental circumstantial wrongful immunity training that is mostly self-corrected by the own immune system, from in-vivo trial and error or from ex-vivo retraining supplementation.

It also applies to the fluid/tissue/organ donation industry that leads to immune system rejection and external intervention immunity suppression, that then leads to immune-regeneration vulnerability of the body to pathogens/cancer/toxin/trauma.

Allergies, Multi-Sclerosis, Rheumatoid Arthritis, Castleman disease, Celiac disease, Diabetes Mellitus type 1, Henoch–Schonlein purpura, Systemic Lupus Erythematosus, Sjogren syndrome, Eosinophilic Granulomatosis with polyangiitis, Hashimoto's thyroiditis, Graves' disease, Idiopathic thrombocytopenic purpura, Addison's disease, Ankylosing Spondylitis, Polymyositis, Dermatomyositis (etc.), or any dysfunction of the immune system leading to an attack on healthy proteins, cells, tissues and organs of Human body.

Prevention-Cure with natural low cost high efficiency IUI Individual Universal Immunotherapy C-Life-IUI-CBM-SAV-SAS-SAT-SLR. Ex-vivo immune system retraining can compensate/complement in-vivo retraining/self-correcting in-vivo deficiency or wrongful/risky allopathic medicine immunity suppression.

Rare circumstances lead to so called auto immune disease that would require biological medicine intervention, but the current allopathic medicine mainstream industry uses anti-symptomatic drugs (chemicals or artificial alo-biologic agents as monoclonal antibodies or car-t cells). These are anti natural defense immune system, suppressing the immune system as the main technology paradigm, which is under 20% efficient or mainly inefficient/ineffective. It contributes to avoid in-vivo self-correction or ex-vivo induced correction and exposes the body to pathogens, cancer, trauma, lack of effective defense and regeneration.

C-Life Cubic Cell Culture Life

Immune cells as B/T/D cells can be cultivated ex-vivo and exposed to Human proteins, cells, tissues, that may be wrongfully triggering an immune response and to antigens that probably induced the immune response, as pathogens, toxins, cancer. Extracted blood immune cells can be retrained and replicated ex-vivo.

Individual ex-vivo cell culture new blood with same embryo genetic DNA can regenerate, reform, repair, replace, revoke cells, to correct circumstantial advantageous general species genetic regeneration decline, adding ex-vivo proteins and/or protein producing mRNA to supplement defects.

C-Life combines CBM, Cell Bank Medculture and IUI, Individual Universal Immunotherapy to create ex-vivo supplementation to the similar in-vivo process, but in a reduced space/time to increase efficiency and to eliminate harmful conditions including autoimmune deficiencies, adding efficient quantities/types.

IUI Individual Universal Immunotherapy

Extracted immune cells and new cells can be trained ex-vivo to distinguish between healthy cells and unhealthy cells or pathogens/toxins or any cause of autoimmunity disease. Multi Sclerosis attack on Neuron cell myelin protein, probably originating in virus/toxin/bacteria/cancer history can be reversed by ex-vivo immune cell retraining.

Immune cells are extracted from the patient and exposed to Human proteins/cells, antigens or a small load of pathogens in a controlled environment outside the body. This process helps train immune cells to recognize/attack the pathogen, determining quantity/type that is most effective, given an autoimmunity vulnerability and recognize/protect Human proteins/cells that are being wrongfully attacked in-vivo.

These trained immune cells are activated and expanded in number to ensure a robust response to antigens and lack of response to Human proteins/cells when reintroduced into the body. The activated and expanded immune cells are infused back into the patient. These cells/antibodies are now better quantified/equipped to recognize/combat pathogens and to recognize and not attack Human cells/proteins.

CBM Cell Bank Medculture

Cultivating cells/proteins ex-vivo, replicating the in-vivo defense process, can increase efficiency against autoimmunity deficiencies. It is more efficient than traditional artificial allopathic treatments that also have collateral effects.

Biologic Medicine of Permanent Life is based on natural technology paradigm, so the healthy in-vivo process that is +95% efficient can be replicated ex-vivo to reduce the 5% inefficiency in-vivo to close to zero. Exposing new cells to previous pathogen antigens and healthy proteins/cells can retrain/test these cells for in-vivo action or lack of action.

SAV Super Auto Vaccine

Exposure to previous antigens and antibodies can also retrain the immune system for the correct response, self-correcting the attack on human proteins that are being confused as a non-human or foreign protein/cell/fluid/tissue/organ.

Ex-vivo non-Human mRNA/vDNA can produce antigens to be loaded in individual immune cells and introduced in-vivo. In-vivo non-Human mRNA vaccines can trigger immune response or trigger benign response and should be avoided. Human mRNA vaccines can produce Human antigens as cancer cells.

vDNA Vector Vaccines interact with Human DNA and can generate immune response or benign non-immune response confusing the immune system. The natural in-vivo immune paradigm should be preserved and replicated in-vivo and ex-vivo.

SAS Super Auto Supplement

Supplementing ex-vivo retrained immune cells, antibodies, antigen loaded immune cells, can lead to an in-vivo self-correcting of attack on healthy cells and reinforce attack on pathogens/unhealthy cells that probably triggered an over reaction that included healthy proteins/cells/tissues/organs.

SAT Super Auto Test

MeScope, microfluid saliva, blood, urine, mucus, sweat, tear and fecal matter can identify autoimmunity deficiencies, human/non-human proteins/cells/antigens via photonic imaging of cell phone, accessory lenses and network HAI, Human Artificial Intelligent enlargement/analysis, complemented by mini testing in mini-laboratory.